Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Wounds and Injuries | 6 | 2024 | 2517 | 1.110 |
Why?
|
Injury Severity Score | 3 | 2024 | 1049 | 0.910 |
Why?
|
Trauma Centers | 5 | 2024 | 951 | 0.870 |
Why?
|
Survivors | 4 | 2024 | 2383 | 0.750 |
Why?
|
Hot Temperature | 1 | 2020 | 1441 | 0.440 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2022 | 709 | 0.250 |
Why?
|
Bell Palsy | 1 | 2023 | 39 | 0.210 |
Why?
|
Myelitis, Transverse | 1 | 2022 | 40 | 0.200 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2022 | 1459 | 0.200 |
Why?
|
Drugs, Chinese Herbal | 1 | 2023 | 147 | 0.180 |
Why?
|
Scrotum | 1 | 2020 | 118 | 0.170 |
Why?
|
Spermatogenesis | 1 | 2020 | 260 | 0.160 |
Why?
|
Frail Elderly | 1 | 2024 | 781 | 0.160 |
Why?
|
Status Epilepticus | 1 | 2023 | 463 | 0.150 |
Why?
|
Tissue Plasminogen Activator | 1 | 2023 | 1165 | 0.140 |
Why?
|
Cooperative Behavior | 1 | 2024 | 1515 | 0.140 |
Why?
|
Testis | 1 | 2020 | 784 | 0.140 |
Why?
|
Renal Insufficiency | 1 | 2022 | 812 | 0.130 |
Why?
|
Spermatozoa | 1 | 2020 | 632 | 0.130 |
Why?
|
Activities of Daily Living | 1 | 2024 | 2434 | 0.120 |
Why?
|
Iran | 3 | 2023 | 763 | 0.120 |
Why?
|
Surgical Wound Infection | 1 | 2024 | 1547 | 0.120 |
Why?
|
Seizures | 2 | 2024 | 3000 | 0.110 |
Why?
|
Patient Discharge | 2 | 2024 | 3491 | 0.110 |
Why?
|
Patient Care Team | 1 | 2024 | 2528 | 0.100 |
Why?
|
Liver Diseases | 1 | 2021 | 1305 | 0.100 |
Why?
|
Intensive Care Units | 1 | 2024 | 3800 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 1 | 2024 | 3683 | 0.080 |
Why?
|
Epilepsy | 1 | 2023 | 3326 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3250 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10400 | 0.070 |
Why?
|
Humans | 22 | 2024 | 768970 | 0.070 |
Why?
|
Immunotherapy | 1 | 2022 | 4756 | 0.070 |
Why?
|
Body Mass Index | 1 | 2024 | 13055 | 0.070 |
Why?
|
Quality of Life | 2 | 2024 | 13510 | 0.060 |
Why?
|
Aorta, Thoracic | 2 | 2022 | 1112 | 0.060 |
Why?
|
Male | 11 | 2024 | 365203 | 0.060 |
Why?
|
Risk Factors | 4 | 2024 | 74976 | 0.060 |
Why?
|
Neoplasms | 2 | 2022 | 22389 | 0.050 |
Why?
|
Altruism | 1 | 2024 | 212 | 0.050 |
Why?
|
Azides | 1 | 2022 | 120 | 0.050 |
Why?
|
Immunotherapy, Adoptive | 2 | 2022 | 1520 | 0.050 |
Why?
|
4-Aminopyridine | 1 | 2022 | 81 | 0.050 |
Why?
|
Middle Aged | 7 | 2024 | 223737 | 0.050 |
Why?
|
Potassium Channel Blockers | 1 | 2022 | 162 | 0.050 |
Why?
|
Endoleak | 1 | 2022 | 111 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8617 | 0.050 |
Why?
|
Deoxyglucose | 1 | 2022 | 333 | 0.050 |
Why?
|
Female | 10 | 2024 | 397515 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8760 | 0.050 |
Why?
|
Methylprednisolone | 1 | 2022 | 386 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9756 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2024 | 81903 | 0.040 |
Why?
|
Laboratories | 1 | 2023 | 463 | 0.040 |
Why?
|
Adult | 5 | 2024 | 223851 | 0.040 |
Why?
|
Aged | 7 | 2024 | 171786 | 0.040 |
Why?
|
Social Isolation | 1 | 2021 | 366 | 0.040 |
Why?
|
Chemokines | 1 | 2022 | 963 | 0.040 |
Why?
|
Operating Rooms | 1 | 2024 | 793 | 0.040 |
Why?
|
Blood Vessel Prosthesis | 1 | 2022 | 957 | 0.040 |
Why?
|
Geriatric Assessment | 1 | 2024 | 1422 | 0.030 |
Why?
|
Mice | 2 | 2021 | 82072 | 0.030 |
Why?
|
United States | 1 | 2024 | 73186 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2023 | 65480 | 0.030 |
Why?
|
ROC Curve | 1 | 2023 | 3629 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21188 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21547 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2023 | 2055 | 0.030 |
Why?
|
Recovery of Function | 1 | 2024 | 2990 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2023 | 2080 | 0.030 |
Why?
|
Antioxidants | 1 | 2021 | 1673 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2211 | 0.030 |
Why?
|
Burns | 1 | 2024 | 1901 | 0.030 |
Why?
|
Surgical Procedures, Operative | 1 | 2024 | 1941 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2022 | 2059 | 0.030 |
Why?
|
Animals | 2 | 2021 | 169335 | 0.020 |
Why?
|
Critical Care | 1 | 2024 | 2716 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3438 | 0.020 |
Why?
|
Health Status | 1 | 2024 | 4095 | 0.020 |
Why?
|
Stents | 1 | 2022 | 3200 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3139 | 0.020 |
Why?
|
Patient Readmission | 1 | 2024 | 3313 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54962 | 0.020 |
Why?
|
Mental Health | 1 | 2024 | 3275 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3952 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 12806 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12467 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3421 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10592 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5369 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12873 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12562 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9264 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18435 | 0.010 |
Why?
|
Pandemics | 1 | 2024 | 8749 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2023 | 7957 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26395 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10868 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2023 | 39394 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10847 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 30046 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41808 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59739 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 60131 | 0.010 |
Why?
|
Concepts
(104)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_